Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Lanini

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020Emanuele Nicastri, Alessandra D'Abramo, Giovanni Faggioni, et al.
Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyValentina Mazzotta, Alessandro Cozzi Lepri, Giulia Matusali, et al.
Journal of Medical Virology|May 6, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target TrialsValentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.
Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.
Cell Reports. Medicine|June 14, 2023
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trialStefania Capone, Francesco M Fusco, Stefano Milleri, et al.
Open Forum Infectious Diseases|October 19, 2020
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 PneumoniaFrancesco Salton, Paola Confalonieri, G Umberto Meduri, et al.
Viruses|September 16, 2020
Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce InvestigationFrancesco Vairo, Martin Parfait Aimè Coussoud-Mavoungou, Francine Ntoumi, et al.
The Journal of Infectious Diseases|September 18, 2016
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Romy Kerber, Ralf Krumkamp, Boubacar Diallo, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020Emanuele Nicastri, Alessandra D'Abramo, Giovanni Faggioni, et al.
Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyValentina Mazzotta, Alessandro Cozzi Lepri, Giulia Matusali, et al.
Journal of Medical Virology|May 6, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target TrialsValentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.
Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.
Cell Reports. Medicine|June 14, 2023
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trialStefania Capone, Francesco M Fusco, Stefano Milleri, et al.
Open Forum Infectious Diseases|October 19, 2020
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 PneumoniaFrancesco Salton, Paola Confalonieri, G Umberto Meduri, et al.
Viruses|September 16, 2020
Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce InvestigationFrancesco Vairo, Martin Parfait Aimè Coussoud-Mavoungou, Francine Ntoumi, et al.
The Journal of Infectious Diseases|September 18, 2016
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Romy Kerber, Ralf Krumkamp, Boubacar Diallo, et al.
Pageof 10